Evaluation of Feasibility of Radial Access for Primary Angioplasty and to Assess it in High Risk Subgroups

Overview

Primary percutaneous coronary intervention is the preferred treatment for patients with ST-segment acute coronary syndrome. The radial access is an established approach, associated with a reduction in vascular access related complications after primary percutaneous coronary interventions. The purpose of this study is to examine the baseline characteristics, risk factors, procedural parameters and complications in patients with STEMI taken for primary angioplasty by radial access. Data of all patients with acute STEMI with primary PCI through radial access is to be evaluated for baseline characteristics and procedural parameters and complications. Patients in the prospective study are followed up till discharge and any in-hospital complication noted. This was a prospective, observational and descriptive study. Three hundred fifteen consecutive patients with an ST-segment elevation acute myocardial infarction (STEMI) treated with primary angioplasty by radial access, admitted between March 2016 and Feb 2017 were analyzed for their baseline characteristics, risk factors, and procedural parameters, complications and outcomes. High risk sub-groups analysis was also done. High risk groups includes patients with age >75yrs, cardiogenic shock, severe LV systolic dysfunction, acute left ventricular failure, high degree AV block, right ventricular infarction and low BMI. The study is conducted among patients with acute STEMI, considered for primary PCI through radial artery access at operator discretion. This study analyzed the baseline characteristics of patients which includes clinical history, clinical examination, ECG, 2D ECHO, coronary angiogram to evaluate cardiovascular risk factors.

Full Title of Study: “A Prospective Study to Evaluate Feasibility of Routine Use of Radial Access for Primary Angioplasty and to Assess it in Subgroups With Unfavorable Characteristics”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: February 28, 2017

Clinical Trial Outcome Measures

Primary Measures

  • Evaluation of radial angioplasty success in whole cohort.
    • Time Frame: one year
    • Angioplasty success rate (by TIMI flow grade)
  • Evaluation of in-hospital complication.
    • Time Frame: One year
    • Rate of local complications

Secondary Measures

  • High risk v/s non-high risk subgroup analysis
    • Time Frame: one year
    • Non- inferiority of radial angioplasty for high risk group were assessed.

Participating in This Clinical Trial

Inclusion Criteria

  • All patients presenting with STEMI and being considered for primary PCI through radial access between March 2016 and Feb 2017. Exclusion Criteria:

  • Patients with ACS other than STEMI – All primary PCI in STEMI through femoral access. – All radial elective PCI.

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Jubilee Mission Medical College and Research Institute
  • Provider of Information About this Clinical Study
    • Principal Investigator: Dr Rajesh Sharma, Senior Resident – Jubilee Mission Medical College and Research Institute
  • Overall Official(s)
    • Rajesh Sharma, MD, Principal Investigator, Jubilee Mission Medical College & Research Institute

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.